DOI:
10.1055/s-00043364
Pharmaceutical Fronts
LinksClose Window
References
Shi D, Zhan X, Yu X. et al.
Inhibiting CB1 receptors improves lipogenesis in an in vitro non-alcoholic fatty liver disease model.
Lipids Health Dis 2014;
13: 173
We do not assume any responsibility for the contents of the web pages of other providers.